Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chrono-chemotherapy vs Routine Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
NCT02187315Phase 2Unknown
- Start
- May 2014
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin in nasopharyngeal carcinoma (NPC) (2 arms). Primary endpoint: Number of Participants with Adverse Events as a Measure of Safety at 5 year. Status: unknown.
02
Drugs
cisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02187315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02187315.